Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kalka Investment Management is a small U.S.-based hedge fund and asset manager founded by former healthcare stock analyst Weidong Huang. It manages less than $150 million in assets across at least one private hedge fund but does not operate as a life sciences/pharma/biotech or healthcare product company. There are no drugs in development nor any clinical programs associated with this firm—it invests capital rather than develops therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kalka Investment Management.